Publication Cover
Redox Report
Communications in Free Radical Research
Volume 12, 2007 - Issue 5
365
Views
25
CrossRef citations to date
0
Altmetric
Research Articles

Oxidative modifications of cardiac mitochondria and inhibition of cytochrome c oxidase activity by 4-hydroxynonenal

, , , , &
Pages 211-218 | Published online: 19 Jul 2013

REFERENCES

  • Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001; 1504: 196–219.
  • Martinez-Sanchez G, Giuliani A, Perez-Davison G, Léon-Fernandez OS. Oxidized proteins and their contribution to redox homeostasis. Redox Report 2005; 10: 175–185.
  • Szweda LI, Uchida K, Tsai L, Stadtman ER. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem 1993; 268: 3342–3347.
  • Uchida K, Stadtman ER Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosohate dehydrogenase. J Biol Chem 1993; 268: 6388–6393.
  • Hemandez-Hemandez A, Garabatos MN, Rodriguez MC et al. Struct-ural characteristics of a lipid peroxidation product, trans-2-nonenal, that favour inhibition of membrane-associated phosphotyrosine phosphatase activity Biochim Biophys Acta 2005; 1726: 317–325.
  • Petersen DR, Doom JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004; 37: 937–945.
  • Seema D, Abha S, Brad P, Rajendra S, Awasthi YC. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Report 2007; 12: 4–10.
  • Siow RC, Ishii T, Mann GE. Modulation of antioxidant gene expres-sion by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox Report 2007; 12: 11–15.
  • Kutuk O, Basaga H. Apoptosis signalling by 4-hydroxynonenal: a role for JNK-c-Jun/AP-1 pathway. Redox Report 2007; 12: 30–34.
  • Chen J, Henderson GI, Freeman GL. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol 2001; 33: 1919–1927.
  • Suh JH, Heath S-H, Hagen TM. Two subpopulations of mitochondria in the aging rat hearts display heterogenous levels of oxidative stress. Free Radic Biol Med 2003; 35: 1064–1072.
  • Yan L-J, Sohal RS. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 1998; 95: 12896–12901.
  • Benderdour M, Charron G, deBlois D, Comte B, Des Rosiers C. Cardiac mitochondrial NADP'-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation. An event that precedes hypertrophy development. J Biol Chem 2003; 278: 45154–45159.
  • Klein SD, Schweizer M, Richter C. Inhibition of the pyridine nucleo-tide-linked mitochondrial Ca' release by 4-hydroxynonenal: the role of thiolate-disulfide conversion. Redox Report 1996; 2: 353–358.
  • Siems W, Hapner SJ, van Kuijk FJGM. 4-Hydroxynonenal inhibits NatIC-ATPase. Free Radic Biol Med 1996; 20: 215–223.
  • Keller JN, Mark RJ, Bruce AJ et al. 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 1997; 80: 685–696.
  • Landar A, Zmijewski JW, Dickinson DA et al. The interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and the formation of reactive oxygen species. Am J Physiol 2006; 290: H1777–H1787.
  • Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005; 38: 1278–1295.
  • Babusikova E, Kaplan P, L,ehotsky J, Jesenak M, Dobrota D. Oxid-ative modification of rat cardiac mitochondrial membranes and myo-fibrils by hydroxyl radicals. Gen Physiol Biophys 2004; 23: 327–335.
  • Capaldi RA, Marusich MF, Taanman J-W. Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells. Methods Enzymol 1995; 260: 117–132.
  • Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem 1986; 261: 10282–10289.
  • Kaplan P, Babusikova E, L,ehotsky J, Dobrota D. Free radical-induced protein modification and inhibition of Ca2tATPase of cardiac sarcoplasmic reticulum. Mol Cell Biochem 2003; 248: 41–47.
  • Kaplan P, Doval M, Majerova Z, L,ehotsky J, Racay P. Iron-induced lipid peroxidation and protein modification in endoplasmic reticulum membranes. Protection by stobadine. Int J Biochem Cell Biol 2000; 32: 539–547.
  • Shimasaki H. Assay of fluorescent lipid peroxidation products. Methods Enzymol 1994; 233: 338–346.
  • Giulivi C, Davies KJA. Dytyrosine: a marker for oxidatively modified proteins and selective proteolysis. Methods Enzymol 1994; 233: 363–371.
  • Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 2000; 466: 323–326.
  • Barone MC, Darley-Usmar VM, Brookes PS. Reversible inhibition of cytochrome c oxidase by peroxynitrite proceeds through ascorbate-dependent generation of nitric oxide. J Biol Chem 2003; 278: 27520–27524.
  • Chen J, Schenker S, Frosto TA, Henderson GI. Inhibition of cytochrome-c oxidase activity by 4-hydroxynonenal (FINE). Role of FINE adduct formation with the enzyme subunits. Biochim Biophys Acta 1998; 1380: 336–344.
  • Musatov A, Carroll CA, Liu Y-C, Henderson GI, Weintraub ST, Robinson NC. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry 2002; 41: 8212–8220.
  • Humphries KM, Szweda LI. Selective inactivation of a-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 1998; 37: 15835–15841.
  • Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Asp Med 2003; 24: 167–175.
  • Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. New York: Oxford University Press, 1999.
  • Schaur RI. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Asp Med 2003; 24: 149–159.
  • Xu G, Liu Y, Sayre LM. Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (INE)-derived lysine-lysine cross-link: characte-rization and application to FINE-treated protein and in vitro oxidized low-density lipoprotein. Chem Res Toxicol 2000; 13: 406–413.
  • Friguet B, Stadtman ER, Szweda LI. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 1994; 269: 21639–21643.
  • Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987; 262: 3603–3608.
  • Esterbauer H, Koller E, Slee RG, Koster JF. Possible involvement of the lipid-peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem J1986; 239: 405-409.
  • Awasthi YC, Chuang TF, Keenan TW, Crane FL. Association of cardiolipin and cytochrome c oxidase. Biochem Biophys Res Commun 1970; 39: 822–832.
  • Cadenas E, Miiller A, Brigelius R, Esterbauer H, Sies H. Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminiscence response, alkane production and glutathione status. Biochem J1983; 214: 479-487.
  • Davies MJ, Fu S, Wang H, Dean RT. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 1999; 27: 1151–1163.
  • Richter 0-MH, Ludwig B. Cytochrome c oxidase structure, function, and physiology of a redox-driven molecular machine. Rev Physiol Biochem Pharmacol 2003; 147: 47–74.
  • Chen JJ, Yu BP. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radic Biol Med 1994; 17: 410–418.
  • Nohl H, Gille L, Kozlov A, Staniek K. Are mitochondria a spontaneous and permanent source of reactive oxygen species? Redox Report 2003; 8: 135–141.
  • Echtay KS, Brand MD. 4-Hydroxy-2-nonenal and uncoupling proteins: an approach for regulation of mitochondrial ROS production. Redox Report 2007; 12: 26–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.